Precision medicine promises the “right drug, right patient” mantra. One piece that sometimes goes missing? A test approved on day one. Jane Li has spent two decades making sure that gap closes on schedule. As senior director of pharma CDx and CRO partnerships at Thermo Fisher Scientific, she has an important role in this complex…
Pangea Biomed’s AI predicts cancer treatment response from histopathology images
What if physicians could predict which cancer treatments will work best for individual patients using just their tumor images? The precision oncology company Pangea Biomed made strides in that direction with the publication of its AI-powered ENLIGHT-DP method in Nature Cancer. This technology taps deep learning, an ever-more-popular type of machine learning with a large…